Clinical unknown node
& research
publication
Wysa has a strong base of clinical evidence in behavioral health, with peer-reviewed trials and efficacy studies across a range of clinical concerns, geographies and age groups.
See our researchResearch Partners
Wysa Receives FDA Breakthrough Device Designation for AI-led Mental Health Conversational Agent
The FDA Breakthrough Device Designation follows an independent peer-reviewed clinical trial, published in JMIR, that found Wysa to be effective in the management of chronic pain, and associated depression and anxiety. The device was found to be more effective than standard orthopedic care, and comparable to in-person psychological counseling.
Research at Wysa
Our behavioural health evidence consists of independent clinical trials that have sought to examine the solution with scientific rigor, and through the lens of real-world implementation. The studies are strongly guided by the voice of the user through co-design and qualitative methodologies, and document our work across clinical concerns of depression, anxiety, pain and chronic conditions.
Peer-Reviewed Research
Wysa has more than 36 peer-reviewed publications in partnership with academic institutions such as Cambridge University, Harvard University and Washington University of St. Louis amongst others, demonstrating the efficacy of Wysa across multiple clinical concerns. Contact us for the entire list of our publications.
Partner with Wysa for Research
We aim to support the innovation and evidence-building within digital mental health and are always looking to connect with researchers.